...
首页> 外文期刊>Nutrition Journal >Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders
【24h】

Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders

机译:最初的饮食/行为治疗后的奥利司他:患有睡眠相关性呼吸障碍的受试者的体重变化和饮食维持

获取原文
           

摘要

Background Sleep related breathing disorders (SRBD) are associated with increased morbidity and mortality and weight loss is recommended to overweight or obese patients with SRBD. However, maintenance of weight loss is difficult to achieve and strategies for weight loss maintenance is needed. Orlistat is a pharmacological agent that reduces the intestinal absorption of fat and may favour long-term weight maintenance. Objective To examine the change in body weight and dietary intake during a 1-year treatment with orlistat after an initial weight loss in obese subjects with SRBD. Furthermore, to explore the dietary determinants of weight maintenance during treatment with orlistat. Methods Men and women with SRBD aged 32-62 years (n = 63) participated in a 3-month dietary intervention to increase intake of vegetables and fruit. After an initial weight loss of 3.4 kg they achieved a mean body mass index of 34.3 ± 4.7 kg/m2. Subsequently they were treated with orlistat for 1 year. During this year, dietary and behavioural interventions to attain weight loss were provided in the course of 14 group sessions. Dietary intake, energy density and food choices were assessed with a food frequency questionnaire before and after orlistat treatment. Results With orlistat, body weight decreased by a mean of 3.5 kg (95% CI 1.5, 5.5). The dietary E% from saturated fat, intake of fatty dairy products and energy density increased after 1 year while intakes of oils, fish and vegetables decreased (all P < 0.05). After multivariate adjustments, weight loss was associated with E% protein (R2adj = 0.19 [95% CI 0.10, 0.46]), and inversely associated with E% saturated fat (R2adj = 0.20 [95% CI 0.12, 0.47]) and fatty dairy products (R2adj = 0.23 [95% CI 0.12, 0.49]). Conclusions Orlistat induced further weight loss, but dietary compliance declined with time. Increasing dietary protein and restricting saturated fat and fatty dairy products may facilitate weight loss with orlistat.
机译:背景睡眠相关的呼吸障碍(SRBD)与发病率和死亡率增加有关,建议超重或肥胖的SRBD患者减轻体重。然而,难以实现维持体重减轻,并且需要维持体重减轻的策略。奥利司他(Orlistat)是一种药物,可减少肠道对脂肪的吸收,并可能有助于长期保持体重。目的研究肥胖性SRBD患者初次体重减轻后奥利司他治疗1年后体重和饮食摄入的变化。此外,探索奥利司他治疗期间维持体重的饮食决定因素。方法SRBD年龄为32-62岁(n = 63)的男女参加了为期3个月的饮食干预,以增加蔬菜和水果的摄入量。最初的体重减轻3.4千克后,他们的平均体重指数达到34.3±4.7千克/平方米。随后,他们接受奥利司他治疗1年。在这一年中,在14个小组会议中提供了减肥的饮食和行为干预措施。奥利司他治疗前后,通过食物频率问卷评估饮食摄入,能量密度和食物选择。结果使用奥利司他,体重平均降低了3.5 kg(95%CI 1.5,5.5)。饱和脂肪,脂肪乳制品的摄入和能量密度的饮食E%在1年后增加,而油,鱼和蔬菜的摄入则减少(所有P <0.05)。经过多变量调整后,体重减轻与E%蛋白质(R2adj = 0.19 [95%CI 0.10,0.46])相关,而与E%饱和脂肪(R2adj = 0.20 [95%CI 0.12,0.47])呈负相关。产品(R2adj = 0.23 [95%CI 0.12,0.49])。结论奥利司他进一步减轻体重,但饮食依从性随时间下降。增加饮食中的蛋白质并限制饱和脂肪和脂肪乳制品可以促进奥利司他的减肥。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号